Impairment of alternative macrophage activation delays cutaneous leishmaniasis in nonhealing BALB/c mice

被引:86
作者
Hölscher, C
Arendse, B
Schwegmann, A
Myburgh, E
Brombacher, F
机构
[1] Univ Cape Town, Inst Infect Dis & Mol Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa
[2] Univ Cape Town, Div Immunol, Fac Hlth Sci, ZA-7925 Cape Town, South Africa
[3] Res Ctr, Jr Res Grp Mol Infect Biol, Borstel, Germany
基金
英国惠康基金;
关键词
D O I
10.4049/jimmunol.176.2.1115
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Expressed on various cell types, the IL-4R alpha is a component of both receptors for IL-4 and IL-13. Susceptibility of BALB/c mice to Leishmania major is believed to be dependent on the development of IL-4- and IL-13-producing Th2 cells, while IFN-gamma secretion by Th1 cells is related to resistance. Despite a sustained development of Th2 cells, IL-4R alpha-deficient BALB/c mice are able to control acute cutaneous leishmaniasis, suggesting that IL-4R alpha-bearing cells other than Th2 cells contribute to susceptibility. To analyze the contribution of the IL-4Ra on macrophages, recently generated macrophage/neutrophil-specific IL-4Ra-deficient mice on a susceptible BALB/c genetic background were infected with L. major. Strikingly, macrophage/neutrophil-specific IL-4Ra-deficient mice showed a significantly delayed disease progression with normal Th2 and type 2 Ab responses but improved macrophage leishmanicidal effector functions and reduced arginase activity. Together, these results suggest that alternative macrophage activation contributes to susceptibility in cutaneous leishmaniasis.
引用
收藏
页码:1115 / 1121
页数:7
相关论文
共 46 条
[1]  
Alexander J, 1999, J CELL SCI, V112, P2993
[2]  
Alexander J, 2002, EUR J IMMUNOL, V32, P2923, DOI 10.1002/1521-4141(2002010)32:10&lt
[3]  
2923::AID-IMMU2923&gt
[4]  
3.0.CO
[5]  
2-E
[6]   IL-9 is a susceptibility factor in leishmania major infection by promoting detrimental Th2/type 2 responses [J].
Arendse, B ;
van Snick, J ;
Brombacher, F .
JOURNAL OF IMMUNOLOGY, 2005, 174 (04) :2205-2211
[7]   Differences between IL-4Rα-deficient and IL-4-deficient mice reveal a role for IL-13 in the regulation of Th2 responses [J].
Barner, M ;
Mohrs, M ;
Brombacher, F ;
Kopf, M .
CURRENT BIOLOGY, 1998, 8 (11) :669-672
[8]   The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure [J].
Belkaid, Y ;
Hoffmann, KF ;
Mendez, S ;
Kamhawi, S ;
Udey, MC ;
Wynn, TA ;
Sacks, DL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (10) :1497-1506
[9]   IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice [J].
Biedermann, T ;
Zimmermann, S ;
Himmelrich, H ;
Gumy, A ;
Egeter, A ;
Sakrauski, AK ;
Seegmüller, I ;
Voigt, H ;
Launois, P ;
Levine, AD ;
Wagner, H ;
Heeg, K ;
Louis, JA ;
Röcken, M .
NATURE IMMUNOLOGY, 2001, 2 (11) :1054-1060
[10]   MECHANISM OF SUPPRESSION OF NITRIC-OXIDE SYNTHASE EXPRESSION BY INTERLEUKIN-4 IN PRIMARY MOUSE MACROPHAGES [J].
BOGDAN, C ;
VODOVOTZ, Y ;
PAIK, J ;
XIE, QW ;
NATHAN, C .
JOURNAL OF LEUKOCYTE BIOLOGY, 1994, 55 (02) :227-233